Related references
Note: Only part of the references are listed.Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes
Francesc Graus et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2021)
Consensus disease definitions for neurologic immune-related adverse events of immune checkpoint inhibitors
Amanda C. Guidon et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Kelch-like Protein 11 Antibodies in Seminoma-Associated Paraneoplastic Encephalitis
Caleigh Mandel-Brehm et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
TRIM9 and TRIM67 Are New Targets in Paraneoplastic Cerebellar Degeneration
Le Duy Do et al.
CEREBELLUM (2019)
The Axon Initial Segment: An Updated Viewpoint
Christophe Leterrier
JOURNAL OF NEUROSCIENCE (2018)
PhIP-Seq characterization of serum antibodies using oligonucleotide-encoded peptidomes
Divya Mohan et al.
NATURE PROTOCOLS (2018)
Antibodies to TRIM46 are associated with paraneoplastic neurological syndromes
Marleen H. van Coevorden-Hameete et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2017)
TRIM46 Controls Neuronal Polarity and Axon Specification by Driving the Formation of Parallel Microtubule Arrays
Sam F. B. van Beuningen et al.
NEURON (2015)
Paraneoplastic encephalomyelopathies: pathology and mechanisms
Andrew McKeon et al.
ACTA NEUROPATHOLOGICA (2011)
Autoantigen discovery with a synthetic human peptidome
H. Benjamin Larman et al.
NATURE BIOTECHNOLOGY (2011)
A new paraneoplastic encephalomyelitis autoantibody reactive with the axon initial segment
Setareh Shams'ili et al.
NEUROSCIENCE LETTERS (2009)
Share Paper
